| |
| |
|
| Insider
Information: |
Dockendorff Charles J |
| Relationship: |
Director |
| City: |
Mansfield |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,453 |
|
|
Indirect Shares
|
93,287 |
|
|
| Direct
Value |
$8,131,275 |
|
|
|
Indirect Value
|
$7,254,868 |
|
|
| Total
Shares |
152,740 |
|
|
| Total
Value |
$15,386,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -74.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covidien Plc |
COV |
EVP & Chief Financial ... |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2023-09-05 |
2,226 |
2023-09-05 |
17,915 |
Premium* |
|
|
Keysight Technologies Inc |
KEYS |
Director |
2024-03-22 |
52,754 |
2023-01-06 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2024-05-09 |
2,901 |
2024-05-09 |
60,002 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2024-03-08 |
1,572 |
2024-03-08 |
15,370 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2020-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,438 |
63,214 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
16,099 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
13,755 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
3,695 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,631 |
64,845 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2021-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,202 |
39,501 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2021-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,077 |
25,400 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
5,260 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2022-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,626 |
63,231 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,877 |
17,079 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
28,130 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2022-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,551 |
55,680 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,844 |
0 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,201 |
0 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2023-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,336 |
0 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
6,725 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2023-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,543 |
51,122 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2023-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,946 |
21,025 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2023-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,226 |
12,441 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
3,037 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2024-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,632 |
52,754 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,901 |
2,901 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2016-02-12 |
4 |
B |
$16.49 |
$494,688 |
D/D |
30,000 |
41,598 |
2.81 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2009-11-10 |
4 |
OE |
$18.20 |
$123,772 |
D/D |
6,800 |
95,756 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2009-11-17 |
4 |
OE |
$18.20 |
$232,983 |
D/D |
12,800 |
101,756 |
0 |
- |
|
143 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
